Kearns & Associates’s Royalty Pharma RPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.55M	Hold	70,740	–	–	1.46%	8
2025 Q1	$2.2M	Buy	70,740 +53,055	+300%	+$1.65M	1.43%	8
2024 Q4	$451K	Buy	+17,685	New	+$451K	0.29%	29